Janssen-Cilag begins marketing of Priligy in New Zealand to treat premature ejaculation
Janssen-Cilag announced that Priligy (dapoxetine) is now approved and available for use in New Zealand for the treatment of premature ejaculation (PE) in men 18-64 years of age.
PE is a common men's medical condition, but it is rarely talked about. However, it is widespread and could affect the quality of life of an estimated 250,000 New Zealand men and their partners .
[adsense:336x280:8701650588]